Laboratoire Dielen Overview
- Year Founded
-
1978
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.63M
- Investors
-
1
Laboratoire Dielen General Information
Description
Operator of a biotechnology company intended to develop and market natural health products recognized by pharmacists and doctors. The company offers food supplement products related to ostéocalm gel, dietary supplements, curcuméga digestion, collagen for skin health and beauty, and mémozan, providing people with a source of nutrients and potential active ingredients for nutritional balance.
Contact Information
Website
www.dielen.frCorporate Office
- Zone Produimer
- Port des Flamands
- 50110 Cherbourg-en-Cotentin
- France
Corporate Office
- Zone Produimer
- Port des Flamands
- 50110 Cherbourg-en-Cotentin
- France
Laboratoire Dielen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 20-Mar-2024 | $1.63M | Completed | Generating Revenue |
Laboratoire Dielen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference |
Laboratoire Dielen Comparisons
Industry
Financing
Details
Laboratoire Dielen Competitors (1)
One of Laboratoire Dielen’s competitors is Abyss Ingredients, a Venture Capital-Backed company based in Caudan, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abyss Ingredients | Venture Capital-Backed | Caudan, France |
Laboratoire Dielen Patents
Laboratoire Dielen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3141617-A1 | Composition for its use in the treatment of irritable bowel syndrome and/or in the treatment of intestinal hyperpermeability. | Pending | 08-Nov-2022 | ||
| EP-4615473-A1 | Composition for use in the treatment of irritable bowel syndrome and/or in the treatment of intestinal hyperpermeability | Pending | 08-Nov-2022 | ||
| WO-2024100153-A1 | Composition for use in the treatment of irritable bowel syndrome and/or in the treatment of intestinal hyperpermeability | Inactive | 08-Nov-2022 | ||
| FR-3116439-A1 | Film-coated tablet containing at least one active ingredient, suitable for oral administration of said at least one active ingredient in human subjects | Active | 26-Nov-2020 | ||
| FR-3116439-B1 | Film-coated tablet containing at least one active ingredient, suitable for oral administration of said at least one active ingredient in human subjects | Active | 26-Nov-2020 | A61K9/209 |
Laboratoire Dielen Signals
Laboratoire Dielen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Seventure | Venture Capital | Minority |
Laboratoire Dielen FAQs
-
When was Laboratoire Dielen founded?
Laboratoire Dielen was founded in 1978.
-
Where is Laboratoire Dielen headquartered?
Laboratoire Dielen is headquartered in Cherbourg-en-Cotentin, France.
-
What is the size of Laboratoire Dielen?
Laboratoire Dielen has 45 total employees.
-
What industry is Laboratoire Dielen in?
Laboratoire Dielen’s primary industry is Biotechnology.
-
Is Laboratoire Dielen a private or public company?
Laboratoire Dielen is a Private company.
-
What is the current valuation of Laboratoire Dielen?
The current valuation of Laboratoire Dielen is .
-
What is Laboratoire Dielen’s current revenue?
The current revenue for Laboratoire Dielen is .
-
How much funding has Laboratoire Dielen raised over time?
Laboratoire Dielen has raised $1.63M.
-
Who are Laboratoire Dielen’s investors?
Seventure has invested in Laboratoire Dielen.
-
Who are Laboratoire Dielen’s competitors?
Abyss Ingredients is a competitor of Laboratoire Dielen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process